Deletion of proline-rich domain in polyomavirus T antigens results in virus partially defective in transformation and tumorigenesis

Virology

Volumn 248, Issue 2, 1998, Pages 420-431

  Yi, Xiande ^a   Freund, Robert ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN DETECTION; ARTICLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; DNA SYNTHESIS INHIBITION; GENE DELETION; MALIGNANT TRANSFORMATION; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVE MUTANT; TUMOR SUPPRESSOR GENE; VIRUS TRANSFORMATION;

ANIMALIA; DNA VIRUSES; PAPOVAVIRIDAE; POLYOMAVIRUS;

EID: 0032168072     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9246     Document Type: Article

References (67)

1. c-src. J. Biol. Chem. 267:1992;5408-5417.
2. Bauer P. H., Bronson R. T., Fung S. C., Freund R., Stehle T., Harrison S. C., Benjamin T. L. Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J. Virol. 69:1995;7925-7931.
3. Benjamin T. L. The hr-t gene of polyoma virus. Biochim. Biophys. Acta. 695:1982;69-95.
4. Bolen J. B., Thiele C. J., Israel M. A., Yonemoto W., Lipsich L. A., Brugge J. S. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell. 38:1984;767-777.
5. Bronson R., Dawe C., Carroll J., Benjamin T. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through shc. Proc. Natl. Acad. Sci. USA. 94:1997;7954-7958.
6. Campbell K. S., Ogris E., Burke B., Su W., Auger K. R., Druker B. J., Schaffhausen B. S., Roberts T. M., Pallas D. C. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (asn-pro-thr-tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA. 91:1994;6344-6348.
7. Carmichael G. G., Benjamin T. L. Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus. J. Biol. Chem. 255:1980;230-235.
8. Carmichael G. G., Schaffhausen B. S., Dorsky D. I., Oliver D. B., Benjamin T. L. Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc. Natl. Acad. Sci. USA. 79:1982;3579-3583.
9. Carmichael G. G., Schaffhausen B. S., Mandel G., Liang T. J., Benjamin T. L. Transformation of polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA. 81:1984;679-683.
10. Coutneidge S. A., Smith A. E. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature. 303:1983;435-439.
11. Cowie A., Villiers J. De, Kamen R. Immortalization of rat embryo fibroblasts by mutant polyomavirus large T antigens deficient in DNA binding. Mol. Cell. Biol. 6:1986;4344-4352.
12. Dahl J., Freund R., Blenis J., Benjamin T. L. Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase. Mol. Cell. Biol. 16:1996;2728-2735.
13. Dahl J., Thathamangalam U., Freund R., Benjamin T. L. Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen. Mol. Cell. Biol. 12:1992;5050-5058.
14. Dawe C. J., Freund R., Mandel G., Ballmer-Hofer K., Talmage D., Benjamin T. L. Variations in polyoma virus genotype in relation to tumor induction in mice: Characterization of wild type strains with widely differing tumor profiles. Am. J. Pathol. 127:1987;243-261.
15. c-src. J. Virol. 64:1993;2235-2244.
16. Dilworth S. M., Brewster C. E., Jones M. D., Lanfrancone L., Pelicci G., Pelicci P. G. Transformation of polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature. 367:1994;87-90.
17. Druker B. J., Ling L. E., Cohen B., Roberts T. M., Schaffhausen B. S. A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity. J. Virol. 64:1990;4454-4461.
18. Dubensky T. W., Villarreal L. P. The primary site of replication alters the eventual site of persistent infection by polyoma virus in mice. J. Virol. 50:1984;541-546.
19. Dubensky T. W., Freund R., Dawe C. J., Benjamin T. L. Polyomavirus replication in mice: Influences of VP1 and route of inoculation. J. Virol. 65:1991;342-349.
20. Dunn, T. B. 1959, Morphology of memory tumors in mice, In, The Physiopathology of Cancer, 38, 84, Heober, New York.
21. Dyson N., Bernards R., Friend S. H., Goodling L. R., Hassel J. A., Major E. O., Pipas J. M., Van Dyke T., Harlow E. Large T antigen of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol. 64:1990;1353-1356.
22. Eckhart W. Complementation between temperature-sensitive and host-range nontransforming mutants of polyoma virus. Virology. 77:1977;589-597.
23. Eddy B. E. Polymer virus. Virol. Monogr. 7:1969;1-114.
24. Eddy B. E., Steward S. E., Grubbs G. E. Influence of tissue culture passage, storage, temperature, and drying on viability of SE polyoma virus. Proc. Soc. Exp. Biol. 99:1958;289-292.
25. Francke B., Eckhart W. Polyoma gene function required for viral DNA synthesis. Virology. 55:1973;127-135.
26. Freund R., Bauer P. H., Crissman H. A., Bradbury E. M., Benjamin T. L. Host range and cell cycle activation properties of polyomavirus large T antigen mutants defective in pRB binding. J. Virol. 68:1994;7227-7234.
27. Freund R., Bronson R. T., Benjamin T. L. Separation of immortalization from tumor induction with polyoma large T mlutants that fail to bind the retinoblastoma gene product. Oncogene. 7:1992a;1979-1987.
28. Freund R., Calderone A., Dawe C. J., Benjamin T. L. Polyomavirus tumor induction in mice: Effects of polymorphisms of VP1 and large T antigen. J. Virol. 65:1991;335-341.
29. Freund R., Dawe C. J., Benjamin T. L. A duplication of non-coding sequences in polyoma virus is required for the development of thymic tumors in mice. J. Virol. 62:1988;3896-3899.
30. Freund R., Dawe C. J., Carroll J. P., Benjamin T. L. Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am. J. Pathol. 141:1992b;1409-1425.
31. Freund R., Mandel G., Carmichael G. G., Barncastle J., Dawe C. J., Benjamin T. L. Polyomavirus tumor induction in mice: Influences of viral coding and non-coding sequences on tumor profiles. J. Virol. 61:1987;2232-2239.
32. Fried M. Characterization of a temperature-sensitive mutant of polyoma virus. Virology. 40:1970;605-617.
33. Griffin B. E., Ito Y., Novak U., Spurr N., Dilworth S., Smolar N., Plllak R., Smith K., Rifkin D. B. early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: Is polyoma virus middle T antigen a transforming gene product. Cold Spring Harbor Symp. Quant. Biol. 44:1980;271-282.
34. Gross, L. 1983, Oncogenic Viruses, 737, 828, Pergamon Press, Oxford.
35. Harlow, E. Lane, D. 1988, In, Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
36. Holman P. S., Gjoerup O. V., Davin T., Schaffhausen B. S. Characterization of an immortalizing N-terminal domain of polyomavirus large T antigen. J. Virol. 68:1994;668-673.
37. Kaplan D. R., Whitman M., Schaffhausen B. S., Raptis L., Garcea R. L., Pallas D. C., Roberts T. M., Cantley L. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc. Natl. Acad. Sci. USA. 83:1986;3624-3628.
38. Kornbluth S., Sudol M., Hanafusa H. Association of the polyomavirus middle-T antigen with c-yes protein. Nature. 325:1987;171-173.
39. Larose A., Dyson N., Sullivan M., Harlow E., Bastin M. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J. Virol. 65:1991;2308-2313.
40. Ling L. E., Druker B. J., Cantley L. E., Roberts T. M. Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase products in intact cells. J. Virol. 66:1992;1702-1708.
41. Magnusson G., Nilsson M. G., Dilworth S. M., Smolar N. Characterization of polyoma mutants with altered middle and large T-antigens. J. Virol. 39:1981;673-683.
42. Markland W., Oostra B. A., Harvey R., Marikham A. F., Colledge W. H., Smith A. E. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250. J. Virol. 59:1986;384-391.
43. Markland W., Smith A. E. Mutants of polyomavirus middle-T antigen. Biochim. Biophys. Acta. 907:1987;299-321.
44. Mudrak I., Ogris E., Rotheneder H., Wintersberger E. Coordinated trans activation of DNA synthesis and precursor producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein. Mol. Cell. Biol. 14:1994;1886-1892.
45. Pallas D. C., Fu H., Haehnel L. C., Weller W., Collier R. J., Roberts T. M. Association of polyomavirus middle tumor antigen with 14-3-3 proteins. Science. 265:1994;535-537.
46. Pallas D. C., Schley C., Mahoney M., Harlow E., Schaffhausen B. S., Roberts T. M. Polyomavirus small t antigen: Overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J. Virol. 60:1986;1075-1084.
47. Pallas D. C., Sharhrik L. K., Martin B. L, Jaspers S., Miller T. B., Brautigan D. L., Roberts T. M. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell. 60:1990;167-176.
48. Rassoulzadegan M., Naghashfar Z., Cowie A., Grisoni M., Kamen R., Cuzin F. Expression of the large T antigen of polyomavirus promotes the establishment in culture of "normal" rodent fibroblast cell lines. Proc. Natl. Acad. Sci. USA. 80:1983;4345-4358.
49. Ren R., Mayer B. J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 259:1993;1157-1161.
50. Rowe W. P., Hartley J. W., Estes J. D., Huebner R. J. Studies of mouse polyoma virus infection. I. Procedures for quantitation and detection of virus. J. Exp. Med. 109:1959;379-391.
51. Sahli R., Freund R., Dubensky T., Garcea R., Bronson R., Benjamin T. Defect in entry and altered pathogenicity of a polyoma virus mutant blocked in VP2 myristylation. Virology. 192:1993;142-153.
52. Sambrook, J. Fritsch, E. F. Maniatis, T. 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
53. Schaffhausen B. S., Benjamin T. L. Phosphorylation of polyoma T antigens. Cell. 18:1979;935-946.
54. Schlegel R., Benjamin T. L. Cellular alterations dependent upon the polyoma virus hr-t function: Separation of mitogenic from transforming capacities. Cell. 14:1978;587-599.
55. Sheng Q., Denis D., Ratnofsky M., Roberts T. M., DeCaprio J. A., Schaffhausen B. The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function. J. Virol. 71:1997;9410-9416.
56. Smolar N., Griffin B. E. DNA sequences of polyoma virus early deletion mutants. J. Virol. 38:1981;8-967.
57. Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:1982;327-332.
58. Su W., Liu W., Schaffhausen B. S., Roberts T. M. Association of polyomavirus middle tumor antigen with phospholipase C-g1. J. Biol. Chem. 270:1995;12331-12334.
59. c-src.. Cell. 59:1989;55-65.
60. Talmage D. A., Freund R., Dubensky T., Salcedo M., Gariglio P., Rangel L. M., Dawe C. J., Benjamin T. L. Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse. Virology. 187:1992;734-747.
61. Tooze, J. 1980, DNA tumor viruses, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
62. Turler, H. Beard, P. 1985, Virology: A Practical Approach, B. W. J. Mahy, 169, 192, IRL Press, Oxford.
63. Walter G., Ruediger R., Slaughter C., Mumby M. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. USA. 87:1990;2521-2525.
64. Whitman M., Kaplan D. R., Schaffhausen B. S., Cantley L., Roberts T. M. Association of phosphatidylinositol kinase activity with polyoma middle T competent for transformation. Nature. 315:1985;239-242.
65. Winocour E. Purification of polyoma virus. Virology. 19:1963;158-168.
66. Yi X., Peterson J., Freund R. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in shc binding. J. Virol. 71:1997;6279-6286.
67. Yu H., Chen J. K., Feng S., Dalgarno D. C., Brauer A. W., Schreiber S. L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 76:1994;933-945.